Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Pharma channel feed
White House budget request would cut billions at NIH and CDC, add $500M for MAHA
Last month
FDA+
FDA withdraws two final guidances, pulls compliance deadlines for bone allograft makers
Last month
R&D
FDA+
Missing REMS delays Cytokinetics' heart drug PDUFA, stock drops
Last month
FDA+
HHS launches $500M universal vaccine platform as RFK Jr. shakes up US vaccine policy
Last month
Coronavirus
Amgen says FDA hold is lifted on its Phase 1 obesity candidate as MariTide enters Phase 3
Last month
FDA adcomms slated to review data on long-term opioid use, overdoses
Last month
FDA+
Lilly CEO Ricks urges Trump to drop drug tariff plan
Last month
Manufacturing
Moderna, facing revenue misses and political headwinds, disappoints Wall Street
Last month
R&D
US drugmakers increasingly look abroad for clinical trials as confidence in FDA wavers
Last month
In Focus
FDA approves Satsuma's migraine nasal spray after rejection in 2024
Last month
FDA+
Biogen says Leqembi sales are improving slowly following lackluster launch
Last month
Lilly meets sales expectations, but Novo gains on PBM win
Last month
Amicus grabs Dimerix’s rare kidney disease drug for $30M upfront
Last month
Deals
Moderna expands effort to rein in costs in an ‘uncertain environment’
Last month
R&D
BeiGene scores a win from US Patent Office in spat over Brukinsa
Last month
Law
Regeneron loses bid to fend off DOJ fight over Eylea Medicare payments
Last month
Law
FDA approves J&J's rare disease drug that's expected to compete with argenx and UCB
Last month
FDA+
Updated: Novartis to buy Regulus Therapeutics for up to $1.7B
Last month
Deals
GSK's supply chain 'reset' after Haleon spinoff to ease tariff impact, CEO says
Last month
Manufacturing
BridgeBio’s Attruby outperforms sales expectations, shares rise
Last month
Pfizer CEO Bourla suggests pharma tariffs will focus on US adversaries, not allies
Last month
China
Join us at 12 p.m. ET: How pharma is reacting to ‘Liberation Day’
Last month
Editor's note
FDA approves Abeona’s skin disease cell therapy
Last month
Cell/Gene Tx
FDA+
With a new CEO, oligonucleotide biotech Creyon forges Eli Lilly partnership
Last month
Financing
Startups
First page
Previous page
4
5
6
7
8
9
10
Next page
Last page